Neuroblastoma trials in Norway

5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma

  Where

  Bergen, Oslo

  Age

  18 months to 64 years

  People

  24 worldwide

  Run by

  Jakob Stenman

  See details and how to joinNCT04903899 · EU 2023-503684-42-00
• Phase 1/2Taking people
  A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies

  Where

  Trondheim

  Age

  Up to 64 years

  People

  72 worldwide

  Run by

  Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

  See details and how to join2023-504880-18-00 · EU 2023-504880-18-00
• Phase 1/2Taking people
  A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

  Where

  Oslo

  Age

  1 year to 64 years

  People

  160 worldwide

  Run by

  University of Birmingham

  See details and how to joinNCT07334301 · EU 2024-516115-24-00
• No phaseTaking people
  SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

  Where

  Oslo

  People

  600 worldwide

  Run by

  Institut Curie

  See details and how to joinNCT05192980
• Phase 3Taking people
  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  Where

  Bergen, Oslo, Tromsø, Trondheim

  Age

  Up to 21 years

  People

  800 worldwide

  Run by

  Gustave Roussy, Cancer Campus, Grand Paris

  See details and how to joinNCT04221035 · EU 2024-514917-36-00